Skip to main content
OpenTrials

Clinical trial condition

Eye Neoplasms

Explore clinical trials studying Eye Neoplasms. Study availability and eligibility vary by location and protocol.

396 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Eye Neoplasms trial results

Recruiting

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

NCT06940739

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +17 more
Locations
  • SCRI Oncology Partners- Denver Denver, Colorado, United States
  • UNC Hospitals, The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Greenslopes Private Hospital Greenslopes, Queensland, Australia
View Trial Details
Recruiting

Neoadjuvant Tebentafusp for Uveal Melanoma

NCT06414590

Conditions
Eye Diseases, Eye Neoplasms, Locally Advanced Unresectable Uveal Melanoma, +12 more
Locations
  • Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • Wills Eye Hospital Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

NCT04855435

Conditions
Advanced Solid Tumor, Cutaneous Melanoma, Eye Diseases, +21 more
Locations
  • Herlev and Gentofte Hospital, Center for Cancer Research Herlev, Denmark
  • Institut Catalá de Oncologia - Hospital Duran i Reynals. Barcelona, Spain
  • Fundacion Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (FJD) Madrid, Spain
  • Centro Integral Oncológico Clara Campal (CIOCC) Madrid, Spain
View Trial Details
Recruiting

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

NCT03947385

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +27 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • San Francisco Oncology Associates San Francisco, California, United States
  • SCRI - Denver Denver, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View all 15 locations
View Trial Details
Recruiting

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

NCT03686124

Conditions
Adnexal Diseases, Cancer, Disease Attributes, +35 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States
  • University of Miami Hospital and Clinics Miami, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 21 locations
View Trial Details
Recruiting

Neoadjuvant Darovasertib in Primary Uveal Melanoma

NCT07015190

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations
  • Mayo Clinic Scottsdale - PPDS Scottsdale, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Jules Stein Eye Institute Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 94 locations
View Trial Details

Related conditions